Author:
Bartlett John M. S.,A’Hern Roger,Piper Tammy,Ellis Ian O.,Dowsett Mitch,Mallon Elizabeth A.,Cameron David A.,Johnston Stephen,Bliss Judith M.,Ellis Paul,Barrett-Lee Peter J.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Peto R (2002) Update of the worldwide evidence on the adjuvant treatment of breast cancer. Eur J Cancer 38:E11
2. Ellis P, Barrett-Lee P, Johnson L et al (2009) Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial. Lancet 373(9676):1681–1692
3. Hayes DF, Thor AD, Dressler LG et al (2007) HER2 and response to paclitaxel in node-positive breast cancer. New Engl J Med 357(15):1496–1506
4. Yang SX, Costantino JP, Kim C et al (2010) Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer. J Clin Oncol 28(18):2974–2981
5. Hu LM, Hofmann J, Lu YL, Mills GB, Jaffe RB (2002) Inhibition of phosphatidylinositol 3 ‘-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 62(4):1087–1092
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献